Mersana Therapeutics logo

Mersana Therapeutics

Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for patients fighting cancer.

159 employees · est. 2001 · Cambridge, United States

VS
Microbion Corporation logo

Microbion Corporation

Developing a disruptive new class of therapeutic drugs for the treatment of rare, chronic, and serious diseases

16 employees · est. 2000 · Bozeman, United States

Microbion Corporation is the older company (2001 vs 2000); Mersana Therapeutics is the larger of the two.

Side-by-Side Comparison

Mersana Therapeutics Microbion Corporation
Founded
2001 2000 older
Headquarters
Cambridge, United States Bozeman, United States
Employees
159 larger 16
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care, Health and Wellness
Funding Stage
Acquired Series Unknown
Total Funding
$534.80M Not tracked yet
Funding Rounds
13 Not tracked yet
Services
Drug Development, Clinical Trials, Patient Resource Support Not tracked yet
Target Customers
Patients with cancer, Healthcare providers, Pharmaceutical partners, Researchers Not tracked yet
Taxonomy
Antibody-Drug Conjugates (ADCs), Cancer Research, Oncology Drug Development, Bioconjugation, Cytotoxic Therapeutics, Immunostimulatory Therapeutics, Biodegradable Polymer Platform, B7-H4 Targeting, HER2 Targeting, Clinical-Stage Biopharmaceuticals Pharmaceuticals, Therapeutics, Drug Development, Clinical-stage Biotechnology, Microbial Biofilm Prevention, Chronic Lung Diseases, Orthopedic Infections, Rare Disease Treatments, Antibiotic Resistance, Inhaled Drug Delivery, Topical Drug Development, Medical Device Coatings, Biofilm Prevention Technologies, Agricultural Biofilm Prevention, Industrial Biofilm Prevention
Website
mersana.com microbioncorp.com
Mersana Therapeutics logo

About Mersana Therapeutics

Mersana Therapeutics, founded in 2001, is a visionary player in the Biotechnology and Health Care sectors, headquartered in the United States. With its mission, "Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for patients fighting cancer," the company stands at...

Microbion Corporation logo

About Microbion Corporation

Microbion Corporation is a clinical-stage pharmaceutical company focusing on developing therapeutic compounds for rare and serious diseases. The company's lead drug candidate, pravibismane, has received substantial support, totaling over $21 million in grants from the Cystic Fibrosis Foundation, NIH...

We will tell you when either one moves

BounceWatch watches Mersana Therapeutics and Microbion Corporation for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Mersana Therapeutics and Microbion Corporation — by email.

Frequently Asked Questions

Mersana Therapeutics — Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for patients fighting cancer.. Microbion Corporation — Developing a disruptive new class of therapeutic drugs for the treatment of rare, chronic, and serious diseases . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Mersana Therapeutics has raised $534.80M while Microbion Corporation has raised undisclosed funding.
Mersana Therapeutics and Microbion Corporation operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Mersana Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Mersana Therapeutics on 9 Jun 2026, and Microbion Corporation on 27 Oct 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy